Impact of COVID‐19 pandemic on epilepsy care in Japan: A national‐level multicenter retrospective cohort study
Abstract Objective The impact of the coronavirus disease 2019 (COVID‐19) pandemic on epilepsy care across Japan was investigated by conducting a multicenter retrospective cohort study. Methods This study included monthly data on the frequency of (1) visits by outpatients with epilepsy, (2) outpatien...
| Main Authors: | , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2022-09-01
|
| Series: | Epilepsia Open |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/epi4.12616 |
| _version_ | 1818010235087880192 |
|---|---|
| author | Naoto Kuroda Takafumi Kubota Toru Horinouchi Naoki Ikegaya Yu Kitazawa Satoshi Kodama Izumi Kuramochi Teppei Matsubara Naoto Nagino Shuichiro Neshige Temma Soga Yutaro Takayama Daichi Sone IMPACT‐J EPILEPSY (In‐depth Multicenter analysis during Pandemic of Covid‐19 Throughout Japan for EPILEPSY practice) study group |
| author_facet | Naoto Kuroda Takafumi Kubota Toru Horinouchi Naoki Ikegaya Yu Kitazawa Satoshi Kodama Izumi Kuramochi Teppei Matsubara Naoto Nagino Shuichiro Neshige Temma Soga Yutaro Takayama Daichi Sone IMPACT‐J EPILEPSY (In‐depth Multicenter analysis during Pandemic of Covid‐19 Throughout Japan for EPILEPSY practice) study group |
| author_sort | Naoto Kuroda |
| collection | DOAJ |
| description | Abstract Objective The impact of the coronavirus disease 2019 (COVID‐19) pandemic on epilepsy care across Japan was investigated by conducting a multicenter retrospective cohort study. Methods This study included monthly data on the frequency of (1) visits by outpatients with epilepsy, (2) outpatient electroencephalography (EEG) studies, (3) telemedicine for epilepsy, (4) admissions for epilepsy, (5) EEG monitoring, and (6) epilepsy surgery in epilepsy centers and clinics across Japan between January 2019 and December 2020. We defined the primary outcome as epilepsy center‐specific monthly data divided by the 12‐month average in 2019 for each facility. We determined whether the COVID‐19 pandemic‐related factors (such as year [2019 or 2020], COVID‐19 cases in each prefecture in the previous month, and a state of emergency) were independently associated with these outcomes. Results In 2020, the frequency of outpatient EEG studies (−10.7%, P < .001) and cases with telemedicine (+2608%, P = .031) were affected. The number of COVID‐19 cases was an independent associated factor for epilepsy admission (−3.75 × 10−3% per case, P < .001) and EEG monitoring (−3.81 × 10−3% per case, P = .004). Furthermore, a state of emergency was an independent factor associated with outpatient with epilepsy (−11.9%, P < .001), outpatient EEG (−32.3%, P < .001), telemedicine for epilepsy (+12,915%, P < .001), epilepsy admissions (−35.3%; P < .001), EEG monitoring (−24.7%: P < .001), and epilepsy surgery (−50.3%, P < .001). Significance We demonstrated the significant impact that the COVID‐19 pandemic had on epilepsy care. These results support those of previous studies and clarify the effect size of each pandemic‐related factor on epilepsy care. |
| first_indexed | 2024-04-14T05:52:42Z |
| format | Article |
| id | doaj.art-c96b89e3905248be88e206cc3601e9d8 |
| institution | Directory Open Access Journal |
| issn | 2470-9239 |
| language | English |
| last_indexed | 2024-04-14T05:52:42Z |
| publishDate | 2022-09-01 |
| publisher | Wiley |
| record_format | Article |
| series | Epilepsia Open |
| spelling | doaj.art-c96b89e3905248be88e206cc3601e9d82022-12-22T02:09:03ZengWileyEpilepsia Open2470-92392022-09-017343144110.1002/epi4.12616Impact of COVID‐19 pandemic on epilepsy care in Japan: A national‐level multicenter retrospective cohort studyNaoto Kuroda0Takafumi Kubota1Toru Horinouchi2Naoki Ikegaya3Yu Kitazawa4Satoshi Kodama5Izumi Kuramochi6Teppei Matsubara7Naoto Nagino8Shuichiro Neshige9Temma Soga10Yutaro Takayama11Daichi Sone12IMPACT‐J EPILEPSY (In‐depth Multicenter analysis during Pandemic of Covid‐19 Throughout Japan for EPILEPSY practice) study groupJapan Young Epilepsy Section (YES‐Japan) Tokyo JapanJapan Young Epilepsy Section (YES‐Japan) Tokyo JapanJapan Young Epilepsy Section (YES‐Japan) Tokyo JapanJapan Young Epilepsy Section (YES‐Japan) Tokyo JapanJapan Young Epilepsy Section (YES‐Japan) Tokyo JapanJapan Young Epilepsy Section (YES‐Japan) Tokyo JapanJapan Young Epilepsy Section (YES‐Japan) Tokyo JapanJapan Young Epilepsy Section (YES‐Japan) Tokyo JapanJapan Young Epilepsy Section (YES‐Japan) Tokyo JapanJapan Young Epilepsy Section (YES‐Japan) Tokyo JapanJapan Young Epilepsy Section (YES‐Japan) Tokyo JapanJapan Young Epilepsy Section (YES‐Japan) Tokyo JapanJapan Young Epilepsy Section (YES‐Japan) Tokyo JapanAbstract Objective The impact of the coronavirus disease 2019 (COVID‐19) pandemic on epilepsy care across Japan was investigated by conducting a multicenter retrospective cohort study. Methods This study included monthly data on the frequency of (1) visits by outpatients with epilepsy, (2) outpatient electroencephalography (EEG) studies, (3) telemedicine for epilepsy, (4) admissions for epilepsy, (5) EEG monitoring, and (6) epilepsy surgery in epilepsy centers and clinics across Japan between January 2019 and December 2020. We defined the primary outcome as epilepsy center‐specific monthly data divided by the 12‐month average in 2019 for each facility. We determined whether the COVID‐19 pandemic‐related factors (such as year [2019 or 2020], COVID‐19 cases in each prefecture in the previous month, and a state of emergency) were independently associated with these outcomes. Results In 2020, the frequency of outpatient EEG studies (−10.7%, P < .001) and cases with telemedicine (+2608%, P = .031) were affected. The number of COVID‐19 cases was an independent associated factor for epilepsy admission (−3.75 × 10−3% per case, P < .001) and EEG monitoring (−3.81 × 10−3% per case, P = .004). Furthermore, a state of emergency was an independent factor associated with outpatient with epilepsy (−11.9%, P < .001), outpatient EEG (−32.3%, P < .001), telemedicine for epilepsy (+12,915%, P < .001), epilepsy admissions (−35.3%; P < .001), EEG monitoring (−24.7%: P < .001), and epilepsy surgery (−50.3%, P < .001). Significance We demonstrated the significant impact that the COVID‐19 pandemic had on epilepsy care. These results support those of previous studies and clarify the effect size of each pandemic‐related factor on epilepsy care.https://doi.org/10.1002/epi4.12616epilepsy centerhospitalizationneurologyneurosurgerySARS‐CoV‐2 |
| spellingShingle | Naoto Kuroda Takafumi Kubota Toru Horinouchi Naoki Ikegaya Yu Kitazawa Satoshi Kodama Izumi Kuramochi Teppei Matsubara Naoto Nagino Shuichiro Neshige Temma Soga Yutaro Takayama Daichi Sone IMPACT‐J EPILEPSY (In‐depth Multicenter analysis during Pandemic of Covid‐19 Throughout Japan for EPILEPSY practice) study group Impact of COVID‐19 pandemic on epilepsy care in Japan: A national‐level multicenter retrospective cohort study Epilepsia Open epilepsy center hospitalization neurology neurosurgery SARS‐CoV‐2 |
| title | Impact of COVID‐19 pandemic on epilepsy care in Japan: A national‐level multicenter retrospective cohort study |
| title_full | Impact of COVID‐19 pandemic on epilepsy care in Japan: A national‐level multicenter retrospective cohort study |
| title_fullStr | Impact of COVID‐19 pandemic on epilepsy care in Japan: A national‐level multicenter retrospective cohort study |
| title_full_unstemmed | Impact of COVID‐19 pandemic on epilepsy care in Japan: A national‐level multicenter retrospective cohort study |
| title_short | Impact of COVID‐19 pandemic on epilepsy care in Japan: A national‐level multicenter retrospective cohort study |
| title_sort | impact of covid 19 pandemic on epilepsy care in japan a national level multicenter retrospective cohort study |
| topic | epilepsy center hospitalization neurology neurosurgery SARS‐CoV‐2 |
| url | https://doi.org/10.1002/epi4.12616 |
| work_keys_str_mv | AT naotokuroda impactofcovid19pandemiconepilepsycareinjapananationallevelmulticenterretrospectivecohortstudy AT takafumikubota impactofcovid19pandemiconepilepsycareinjapananationallevelmulticenterretrospectivecohortstudy AT toruhorinouchi impactofcovid19pandemiconepilepsycareinjapananationallevelmulticenterretrospectivecohortstudy AT naokiikegaya impactofcovid19pandemiconepilepsycareinjapananationallevelmulticenterretrospectivecohortstudy AT yukitazawa impactofcovid19pandemiconepilepsycareinjapananationallevelmulticenterretrospectivecohortstudy AT satoshikodama impactofcovid19pandemiconepilepsycareinjapananationallevelmulticenterretrospectivecohortstudy AT izumikuramochi impactofcovid19pandemiconepilepsycareinjapananationallevelmulticenterretrospectivecohortstudy AT teppeimatsubara impactofcovid19pandemiconepilepsycareinjapananationallevelmulticenterretrospectivecohortstudy AT naotonagino impactofcovid19pandemiconepilepsycareinjapananationallevelmulticenterretrospectivecohortstudy AT shuichironeshige impactofcovid19pandemiconepilepsycareinjapananationallevelmulticenterretrospectivecohortstudy AT temmasoga impactofcovid19pandemiconepilepsycareinjapananationallevelmulticenterretrospectivecohortstudy AT yutarotakayama impactofcovid19pandemiconepilepsycareinjapananationallevelmulticenterretrospectivecohortstudy AT daichisone impactofcovid19pandemiconepilepsycareinjapananationallevelmulticenterretrospectivecohortstudy AT impactjepilepsyindepthmulticenteranalysisduringpandemicofcovid19throughoutjapanforepilepsypracticestudygroup impactofcovid19pandemiconepilepsycareinjapananationallevelmulticenterretrospectivecohortstudy |